Considerations When Implementing Medication-Assisted Treatment for Opioid Dependent Patients

August 13, 2018

Medication-assisted treatment (MAT) for opioid addiction needs all the support it can get. Although state laws increasingly encourage MAT at the same time Suboxone®/buprenorphine waiver limits have expanded, only 1 in 20 active licensed physicians is approved to provide it.*

This whitepaper answers common questions doctors have about MAT, including:

  • Qualifications for a Suboxone®/buprenorphine waiver
  • Evaluating medical necessity for treatment
  • Tests: comparing point of care vs. lab-performed
  • Digital methods to support recovery

* Young A, Chaudhry HJ, Pei X, Arnhart K, Dugan M, Snyder GB. A Census of Actively Licensed Physicians in the United States, 2016. Jour Med Reg. 103; 2:7-21. 2017 / Physician and Program Data. Substance Abuse and Mental Health Services Administration Web site. https://www.samhsa.gov/medication-assisted-treatment/ physician-program-data/. Accessed May 17, 2018